CYTOMEGALOVIRUS PANCREATITIS

This adverse event was reported 10 times

CYTOMEGALOVIRUS PANCREATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE 2 0.0007
1 LEMBOREXANT 2 0.0007
2 RAMELTEON 2 0.0003
3 DOPAMINE HYDROCHLORIDE 1 0.0003
4 FOSCARNET SODIUM 1 0.0002
5 VONOPRAZAN FUMARATE 2 0.0002
6 EFAVIRENZ 2 0.0002
7 EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 2 0.0002
8 MICAFUNGIN SODIUM 1 0.0002
9 DARUNAVIR 2 0.0001
See all drugs enriched for association with CYTOMEGALOVIRUS PANCREATITIS